デフォルト表紙
市場調査レポート
商品コード
1515451

希少バイオマーカー検体収集および安定化市場:バイオマーカー別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測

Rare Biomarkers Specimen Collection and Stabilization Market, By Biomarker, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 303 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
希少バイオマーカー検体収集および安定化市場:バイオマーカー別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

希少バイオマーカー検体収集および安定化市場規模は2023年に369億832万米ドルとなり、2024年から2032年にかけてCAGR 13.90%で拡大

希少バイオマーカー検体収集および安定化市場-市場力学

医薬品開発・臨床試験および生物医学研究の増加が市場需要を促進する見込み

バイオマーカーは、医薬品の有効性と安全性を評価する臨床試験のエンドポイントとしてますます使用されるようになっています。希少バイオマーカーの適切な収集と安定化は、試験結果の信頼性と再現性を確保する上で極めて重要です。さらに、安定化剤、保存条件、輸送システムの改善など、サンプルハンドリング技術の革新により、希少バイオマーカー検体収集および安定化プロセスの信頼性と効率が向上しています。このように、臨床試験からの高い需要と技術の進歩は、市場の成長を促進すると予想されます。

バイオテクノロジーと分子生物学の技術開発により、珍しいバイオマーカーを発見して調べる能力が高まっています。このことは、バイオマーカーの完全性を維持しながら検体を安定させ収集するための信頼できる技術の必要性を強調し、市場の成長に寄与しています。治療は、個別化医療として知られる患者の遺伝的、環境的、バイオマーカープロファイルを考慮した個別化が進んでいます。治療の有効性と転帰に影響を及ぼす患者固有の特徴を突き止めるには、希少バイオマーカーが不可欠です。費用対効果の高いヘルスケアソリューションが重視されるようになってきています。バイオマーカーに基づく診断は、疾患の早期発見や標的治療を可能にすることで、ヘルスケア全体のコストを削減できる可能性があります。

希少バイオマーカー検体収集および安定化市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間(2024-2032年)に約13.90%のCAGRで毎年成長すると予測されています。

バイオマーカーセグメンテーションに基づくと、循環無細胞DNA(ccfDNA)セグメントは、がん治療におけるその高い需要により、2023年に最大の市場シェアを示すと予測されました。

アプリケーション別では、慢性疾患の治療ニーズの高まりにより、診断分野が2023年の主要アプリケーションとなった。

エンドユーザーセグメンテーションに基づくと、研究室セグメントは、医薬品開発と新規研究に高い関心があるため、2023年の主要エンドユーザーでした。

地域別では、政府支援とFDA承認により、北米が2023年に収益でリードしました。

希少バイオマーカー検体収集および安定化市場-セグメンテーション分析:

世界の希少バイオマーカー検体収集および安定化市場は、バイオマーカー、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はバイオマーカーに基づいて3つのカテゴリーに分けられます:円形細胞遊離DNA、循環腫瘍細胞、エクソソーム。円形遊離DNAセグメントは市場を独占しています。血液がんの有病率の高さが主にこのセグメントの成長を後押ししています。

市場は用途別に、診断、トランスクリプトミクス、ファーマコゲノミクス、心血管疾患、その他の5つのカテゴリーに分類されます。診断分野が市場を独占しています。非侵襲性がんの治療や臨床利用のニーズが高まっていることが市場成長を加速しています。

市場はエンドユーザーによって、研究室、病院・診療所、その他の3つに分類されます。研究室セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。DNAおよびRNA医薬品開発における政府およびFDAの承認による奨励の増加が市場開拓を後押ししています。

希少バイオマーカー検体収集および安定化市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。米国を中心とする北米は、高度な生物医学研究と診断のための成熟市場です。主要な学術機関、研究センター、バイオテクノロジー企業の存在など、いくつかの要因が高度な検体収集・安定化技術への需要を後押ししています。さらに、多額のヘルスケア支出と保険適用が、先端診断技術の採用を促進しています。

希少バイオマーカー検体収集および安定化市場-競合情勢:

サーモフィッシャーサイエンティフィック、QIAGEN、BDバイオサイエンシズ、Merck KGaAなど、市場をリードするいくつかの企業は、その広範な製品提供と世界のプレゼンスにより、市場シェアを独占しています。これらの企業は研究開発に投資し、バイオマーカーの保存性と信頼性を向上させる新しい検体採取装置や安定化方法を革新しています。

目次

第1章 希少バイオマーカー検体収集および安定化市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 希少バイオマーカー検体収集および安定化の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 希少バイオマーカー検体収集および安定化の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 希少バイオマーカー検体収集および安定化市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 希少バイオマーカー検体収集および安定化市場情勢

  • 希少バイオマーカー検体収集および安定化市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 希少バイオマーカー検体収集および安定化市場- バイオマーカー別

  • 概要
    • セグメントシェア分析
    • 環状細胞遊離DNA
    • 循環腫瘍細胞
    • エクソソーム

第8章 希少バイオマーカー検体収集および安定化市場- 用途別

  • 概要
    • セグメントシェア分析
    • 診断
    • トランスクリプトミクス
    • 薬理ゲノム学
    • 心血管疾患
    • その他

第9章 希少バイオマーカー検体収集および安定化市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 研究ラボ
    • 病院・診療所
    • その他

第10章 希少バイオマーカー検体収集および安定化市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 希少バイオマーカー検体収集および安定化業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • QIAGEN
    • BD Biosciences
    • Merck KGaA
    • Bio-Rad Laboratories
    • Bio-Techne Corporation
    • GE Healthcare Life Sciences
    • Agilent Technologies
    • Roche Diagnostics
    • LabCorp
    • Promega Corporation
    • Illumina, Inc.
    • Danaher Corporation
    • PerkinElmer, Inc.
    • Eppendorf AG
    • Lonza Group
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Biomarker Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Biomarker
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Application 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by End User 2019-2032 (USD Million)
  • TABLE Rare Biomarkers Specimen Collection and Stabilization Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rare Biomarkers Specimen Collection and Stabilization Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Biomarker, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rare Biomarkers Specimen Collection and Stabilization Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Biomarker segment market share analysis, 2023 & 2030
  • FIGURE Biomarker segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Europe Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Germany Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE India Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Philippines Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Brazil Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV3173

REPORT HIGHLIGHT

Rare Biomarkers Specimen Collection and Stabilization Market size was valued at USD 36,908.32 Million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

Rare biomarkers specimen collection and stabilization refers to the process of obtaining biological samples such as blood, urine, tissue, etc. that contain rare or low-abundance biomolecules, which are substances indicative of biological processes or conditions. These biomarkers may be present in very small quantities in the body and can provide critical information about disease states, treatment responses, or physiological changes.

Rare Biomarkers Specimen Collection and Stabilization Market- Market Dynamics

Rising number of drug development & clinical trials and biomedical research are expected to propel market demand

Biomarkers are increasingly used as endpoints in clinical trials to assess drug efficacy and safety. Proper collection and stabilization of rare biomarkers are critical to ensuring the reliability and reproducibility of trial results. Moreover, innovations in sample handling technologies, such as improved stabilizing agents, storage conditions, and transport systems, enhance the reliability and efficiency of rare biomarker collection and stabilization processes. Thus, high demand from clinical trials & advancement in technology is expected to foster market growth.

Technological developments in biotechnology and molecular biology have increased our capacity to find and examine uncommon biomarkers. This emphasizes the necessity for trustworthy techniques for stabilizing and collecting specimens while maintaining the integrity of the biomarker which is contributing to market growth. Treatments are becoming more individualized considering patient genetic, environmental, and biomarker profiles known as personalized medicine. To pinpoint patient-specific traits that affect therapy efficacy and outcomes, rare biomarkers are essential. There is a growing emphasis on cost-effective healthcare solutions. Biomarker-based diagnostics can potentially reduce overall healthcare costs by enabling early disease detection and targeted therapies.

Rare Biomarkers Specimen Collection and Stabilization Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Biomarker segmentation, circulating cell-free DNA (ccfDNA) segment was predicted to show maximum market share in the year 2023, owing to its high demand in cancer treatment.

Based on Application segmentation, diagnostics segment was the leading application in 2023, due to increased need for chronic disorder care.

Based on End User segmentation, research laboratories segment was the leading End User in 2023, owing to high focus on drug development & novel research.

On the basis of region, North America was the leading revenue generator in 2023, owing to government support & FDA approvals.

Rare Biomarkers Specimen Collection and Stabilization Market- Segmentation Analysis:

The Global Rare Biomarkers Specimen Collection and Stabilization Market is segmented on the basis of Biomarker, Application, End User, and Region.

The market is divided into three categories based on Biomarker: circular cell free DNA, circulating tumor cells, and exosomes. The circular cell free DNA segment dominates the market. High prevalence of blood cancer is primarily boosting segment growth.

The market is divided into five categories based on Application: diagnostics, transcriptomics, pharmacogenomics, cardiovascular diseases, and others. The diagnostics segment dominates the market. The increasing need for treatment of non-invasive cancer and clinical use is accelerating market growth.

The market is divided into three categories based on End User: research laboratories, hospital & clinics, and others. The research laboratories segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing encouragement from government & FDA approvals in DNA & RNA drug development are boosting market growth.

Rare Biomarkers Specimen Collection and Stabilization Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, mainly the United States, is a mature market for advanced biomedical research and diagnostics. Several factors like the presence of leading academic institutions, research centers, and biotechnology companies drive demand for advanced specimen collection and stabilization technologies. In addition, significant healthcare spending and insurance coverage facilitate adoption of advanced diagnostic technologies.

Rare Biomarkers Specimen Collection and Stabilization Market- Competitive Landscape:

The competitive landscape of the rare biomarkers specimen collection and stabilization market is shaped by technological advancements, dominated by major players. some of the leading companies in the market such as Thermo Fisher Scientific, QIAGEN, BD Biosciences, Merck KGaA, etc., dominate market share due to their extensive product offerings and global presence. These companies are investing in research and development to innovate new specimen collection devices and stabilization methods that improve biomarker preservation and reliability.

Recent Developments:

In March 2023, nRichDX partnered with OraSure Technologies, Inc., to market their products for scientists working on liquid biopsy applications.

In May 2023, LabCorp launched LabCorp Plasma Focus, a liquid biopsy test which enables tailored therapy selection for people with advanced or metastatic solid cancers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • QIAGEN
  • BD Biosciences
  • Merck KGaA
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • GE Healthcare Life Sciences
  • Agilent Technologies
  • Roche Diagnostics
  • LabCorp
  • Promega Corporation
  • Illumina, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Eppendorf AG
  • Lonza Group
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY BIOMARKER- MARKET ANALYSIS, 2019-2032

  • Circular Cell Free DNA
  • Circulating tumor cells
  • Exosomes

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Diagnostics
  • Transcriptomics
  • Pharmacogenomics
  • Cardiovascular diseases
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Research laboratories
  • Hospital & clinics
  • Others

GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION AND STABILIZATION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rare Biomarkers Specimen Collection and Stabilization Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Biomarker
    • 2.1.2. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Application
    • 2.1.3. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by End User
    • 2.1.4. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Country
    • 2.1.5. Rare Biomarkers Specimen Collection and Stabilization Market Snippet by Region
  • 2.2. Competitive Insights

3. Rare Biomarkers Specimen Collection and Stabilization Key Market Trends

  • 3.1. Rare Biomarkers Specimen Collection and Stabilization Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rare Biomarkers Specimen Collection and Stabilization Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rare Biomarkers Specimen Collection and Stabilization Market Opportunities
  • 3.4. Rare Biomarkers Specimen Collection and Stabilization Market Future Trends

4. Rare Biomarkers Specimen Collection and Stabilization Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rare Biomarkers Specimen Collection and Stabilization Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rare Biomarkers Specimen Collection and Stabilization Market Landscape

  • 6.1. Rare Biomarkers Specimen Collection and Stabilization Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rare Biomarkers Specimen Collection and Stabilization Market - By Biomarker

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Biomarker, 2024 & 2032 (%)
    • 7.1.2. Circular Cell Free DNA
    • 7.1.3. Circulating tumor cells
    • 7.1.4. Exosomes

8. Rare Biomarkers Specimen Collection and Stabilization Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Diagnostics
    • 8.1.3. Transcriptomics
    • 8.1.4. Pharmacogenomics
    • 8.1.5. Cardiovascular diseases
    • 8.1.6. Others

9. Rare Biomarkers Specimen Collection and Stabilization Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Research laboratories
    • 9.1.3. Hospital & clinics
    • 9.1.4. Others

10. Rare Biomarkers Specimen Collection and Stabilization Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Rare Biomarkers Specimen Collection and Stabilization Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Biomarkers Specimen Collection and Stabilization Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. QIAGEN
    • 11.2.3. BD Biosciences
    • 11.2.4. Merck KGaA
    • 11.2.5. Bio-Rad Laboratories
    • 11.2.6. Bio-Techne Corporation
    • 11.2.7. GE Healthcare Life Sciences
    • 11.2.8. Agilent Technologies
    • 11.2.9. Roche Diagnostics
    • 11.2.10. LabCorp
    • 11.2.11. Promega Corporation
    • 11.2.12. Illumina, Inc.
    • 11.2.13. Danaher Corporation
    • 11.2.14. PerkinElmer, Inc.
    • 11.2.15. Eppendorf AG
    • 11.2.16. Lonza Group
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us